Gordon Worley1, Stephen W Erickson2, Kathryn E Gustafson3, Yuliya S Nikolova4, Allison E Ashley-Koch5, Daniel W Belsky6, Ricki F Goldstein3,7, Grier P Page2, C Michael Cotten3. 1. Division of Pediatric Neurology and Developmental Medicine, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA. 2. Social, Statistical and Environmental Sciences, RTI International, NC, USA. 3. Division of Neonatology, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA. 4. Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada. 5. Duke Molecular Physiology Institute, Department of Medicine, Duke University Medical Center, Durham, NC, USA. 6. Department of Population Health Sciences, Duke University, Durham, NC, USA. 7. Division of Neonatology, Department of Pediatrics, Kentucky Children's Hospital, Chandler Medical Center, University of Kentucky, Lexington, KY, USA.
Abstract
AIM: To determine if genetic variation associated with decreased dopamine neurotransmission predicts a decrease in motor development in a convenience cohort study of infants born extremely-low-birthweight (ELBW). METHOD: Four hundred and ninety-eight infants born ELBW had genome-wide genotyping and a neurodevelopmental evaluation at 18 to 22 months of age, corrected for preterm birth. A polygenic risk score (PRS) was created to combine into one predictor variable the hypothesized influences on motor development of alleles at seven independent single nucleotide polymorphisms previously associated with relative decreases in both dopamine neurotransmission and motor learning, by summing the number of alleles present in each infant (range=0-14). The motor development outcome was the Psychomotor Development Index (PDI) of the Bayley Scales of Infant Development, Second Edition. The linear regression models were adjusted for seven clinical and four genetic ancestry covariates. The mean PRS of infants with cerebral palsy (CP) was compared to those without CP. RESULTS: PRS was inversely related to PDI (p=0.011). Each 1-point increase in PRS resulted in an average decrease in PDI of 1.37 points. Patients with CP did not have a greater mean PRS than those without (p=0.67), both with and without adjustment for covariates. INTERPRETATION: Genetic variation that favors a decrease in dopamine neurotransmission predisposes to a decrease in motor development in infants born ELBW, but not to the diagnosis of CP. WHAT THIS PAPER ADDS: Genetic variation in dopamine neurotransmission was associated with a decrease in motor development in infants born at an extremely-low-birthweight. It does not predispose to the diagnosis of cerebral palsy.
AIM: To determine if genetic variation associated with decreased dopamine neurotransmission predicts a decrease in motor development in a convenience cohort study of infants born extremely-low-birthweight (ELBW). METHOD: Four hundred and ninety-eight infants born ELBW had genome-wide genotyping and a neurodevelopmental evaluation at 18 to 22 months of age, corrected for preterm birth. A polygenic risk score (PRS) was created to combine into one predictor variable the hypothesized influences on motor development of alleles at seven independent single nucleotide polymorphisms previously associated with relative decreases in both dopamine neurotransmission and motor learning, by summing the number of alleles present in each infant (range=0-14). The motor development outcome was the Psychomotor Development Index (PDI) of the Bayley Scales of Infant Development, Second Edition. The linear regression models were adjusted for seven clinical and four genetic ancestry covariates. The mean PRS of infants with cerebral palsy (CP) was compared to those without CP. RESULTS: PRS was inversely related to PDI (p=0.011). Each 1-point increase in PRS resulted in an average decrease in PDI of 1.37 points. Patients with CP did not have a greater mean PRS than those without (p=0.67), both with and without adjustment for covariates. INTERPRETATION: Genetic variation that favors a decrease in dopamine neurotransmission predisposes to a decrease in motor development in infants born ELBW, but not to the diagnosis of CP. WHAT THIS PAPER ADDS: Genetic variation in dopamine neurotransmission was associated with a decrease in motor development in infants born at an extremely-low-birthweight. It does not predispose to the diagnosis of cerebral palsy.
Authors: Stephanie M Gogarten; Tushar Bhangale; Matthew P Conomos; Cecelia A Laurie; Caitlin P McHugh; Ian Painter; Xiuwen Zheng; David R Crosslin; David Levine; Thomas Lumley; Sarah C Nelson; Kenneth Rice; Jess Shen; Rohit Swarnkar; Bruce S Weir; Cathy C Laurie Journal: Bioinformatics Date: 2012-10-10 Impact factor: 6.937
Authors: Regina Hünnerkopf; Alexander Strobel; Lise Gutknecht; Burkhard Brocke; Klaus Peter Lesch Journal: Neuropsychopharmacology Date: 2007-03-28 Impact factor: 7.853
Authors: Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott Journal: Neurotoxicol Teratol Date: 2016-01-21 Impact factor: 3.763
Authors: Kristin M Pearson-Fuhrhop; Brian Minton; Daniel Acevedo; Babak Shahbaba; Steven C Cramer Journal: PLoS One Date: 2013-04-17 Impact factor: 3.240
Authors: Diane L Damiano; James J Pekar; Susumu Mori; Andreia Vasconcellos Faria; X Ye; Elaine Stashinko; Christopher J Stanley; Katharine E Alter; Alec H Hoon; Eric M Chin Journal: Front Rehabil Sci Date: 2022-04-05